biostudies-literatureUnknown12Zhang Y<h4>Background and aims</h4>Microvascular invasion (MVI) is a well-known risk factor for poor prognosis in hepatocellular carcinoma (HCC). This study aimed to develop a deep convolutional neural network (DCNN) model based on contrast-enhanced ultrasound (CEUS) to predict MVI, and thus to predict prognosis in patients with HCC.<h4>Methods</h4>A total of 436 patients with surgically resected HCC who underwent preoperative CEUS were retrospectively enrolled. Patients were divided into training (<i>n</i> = 301), validation (<i>n</i> = 102), and test (<i>n</i> = 33) sets. A clinical model (Clinical model), a CEUS video-based DCNN model (CEUS-DCNN model), and a fusion model based on CEUS video and clinical variables (CECL-DCNN model) were built to predict MVI. Survival analysis was used to evaluate the clinical performance of the predicted MVI.<h4>Results</h4>Compared with the Clinical model, the CEUS-DCNN model exhibited similar sensitivity, but higher specificity (71.4% vs. 38.1%, <i>p</i> = 0.03) in the test group. The CECL-DCNN model showed significantly higher specificity (81.0% vs. 38.1%, <i>p</i> = 0.005) and accuracy (78.8% vs. 51.5%, <i>p</i> = 0.009) than the Clinical model, with an AUC of 0.865. The Clinical predicted MVI could not significantly distinguish OS or RFS (both <i>p</i> > 0.05), while the CEUS-DCNN predicted MVI could only predict the earlier recurrence (hazard ratio [HR] with 95% confidence interval [CI 2.92 [1.1-7.75], <i>p</i> = 0.024). However, the CECL-DCNN predicted MVI was a significant prognostic factor for both OS (HR with 95% CI: 6.03 [1.7-21.39], <i>p</i> = 0.009) and RFS (HR with 95% CI: 3.3 [1.23-8.91], <i>p</i> = 0.011) in the test group.<h4>Conclusions</h4>The proposed CECL-DCNN model based on preoperative CEUS video can serve as a noninvasive tool to predict MVI status in HCC, thereby predicting poor prognosis.Frontiers in oncology878061https://www.ebi.ac.uk/biostudies/studies/S-EPMC9300962biostudies-literatureDeep Learning of Liver Contrast-Enhanced Ultrasound to Predict Microvascular Invasion and Prognosis in Hepatocellular Carcinoma.PMC9300962Cao LLiao YHu YMao RLi QYu JZhou XLi LZou XYao ZHuang YWei QZhang YYan CHan JWang YLin MTang XZhou JfalseDeep Learning of Liver Contrast-Enhanced Ultrasound to Predict Microvascular Invasion and Prognosis in Hepatocellular Carcinoma.<h4>Background and aims</h4>Microvascular invasion (MVI) is a well-known risk factor for poor prognosis in hepatocellular carcinoma (HCC). This study aimed to develop a deep convolutional neural network (DCNN) model based on contrast-enhanced ultrasound (CEUS) to predict MVI, and thus to predict prognosis in patients with HCC.<h4>Methods</h4>A total of 436 patients with surgically resected HCC who underwent preoperative CEUS were retrospectively enrolled. Patients were divided into training (<i>n</i> = 301), validation (<i>n</i> = 102), and test (<i>n</i> = 33) sets. A clinical model (Clinical model), a CEUS video-based DCNN model (CEUS-DCNN model), and a fusion model based on CEUS video and clinical variables (CECL-DCNN model) were built to predict MVI. Survival analysis was used to evaluate the clinical performance of the predicted MVI.<h4>Results</h4>Compared with the Clinical model, the CEUS-DCNN model exhibited similar sensitivity, but higher specificity (71.4% vs. 38.1%, <i>p</i> = 0.03) in the test group. The CECL-DCNN model showed significantly higher specificity (81.0% vs. 38.1%, <i>p</i> = 0.005) and accuracy (78.8% vs. 51.5%, <i>p</i> = 0.009) than the Clinical model, with an AUC of 0.865. The Clinical predicted MVI could not significantly distinguish OS or RFS (both <i>p</i> > 0.05), while the CEUS-DCNN predicted MVI could only predict the earlier recurrence (hazard ratio [HR] with 95% confidence interval [CI 2.92 [1.1-7.75], <i>p</i> = 0.024). However, the CECL-DCNN predicted MVI was a significant prognostic factor for both OS (HR with 95% CI: 6.03 [1.7-21.39], <i>p</i> = 0.009) and RFS (HR with 95% CI: 3.3 [1.23-8.91], <i>p</i> = 0.011) in the test group.<h4>Conclusions</h4>The proposed CECL-DCNN model based on preoperative CEUS video can serve as a noninvasive tool to predict MVI status in HCC, thereby predicting poor prognosis.2022-01-01T00:00:00Z20222025-04-25T19:44:52.999Z2025-04-06T08:07:40.303ZS-EPMC93009623587511010.3389/fonc.2022.878061